Neurostimulation-based Solutions for Diverse Industries
Legal Citation
Summary of the Inventive Concept
The inventive concept applies the core technology of neurostimulation to novel industries and use cases, unlocking new opportunities for improving crop growth, livestock behavior, athletic performance, veterinary medicine, and cognitive function.
Background and Problem Solved
The original patent relates to neurostimulation methods and systems for regulating current in the presence of MRI/EMI interference. While effective in its intended application, the technology's potential extends beyond its original scope. The new inventive concept addresses the limitations of the original patent by exploring its applicability to entirely different industries and fields, where the technology can provide innovative solutions to pressing problems.
Detailed Description of the Inventive Concept
The inventive concept involves adapting the neurostimulation technology to various industries and use cases. For instance, in agriculture, neurostimulation can enhance crop growth by applying electrical stimulation to plants, promoting photosynthesis and nutrient uptake. In livestock management, targeted neurostimulation can improve feeding habits, reduce stress, and enhance overall well-being. In athletics, transcranial electrical stimulation can improve focus, concentration, and reaction time. In veterinary medicine, implantable devices can deliver targeted neurostimulation to manage chronic pain in pets. Finally, personalized neurostimulation protocols can enhance cognitive function in individuals with neurodevelopmental disorders.
Novelty and Inventive Step
The new inventive concept introduces novel applications and use cases that were not considered in the original patent. The inventive step lies in recognizing the potential of neurostimulation technology to address diverse industry-specific challenges, and adapting the technology to meet those needs.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include varying the type and intensity of neurostimulation, using different electrode configurations, or incorporating additional sensors and data analytics to optimize the technology's performance. Variations may also involve integrating the neurostimulation technology with existing systems or platforms in each industry.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential across multiple industries, including agriculture, livestock management, athletics, veterinary medicine, and healthcare. The technology can be marketed as a solution for improving crop yields, enhancing livestock productivity, optimizing athletic performance, managing chronic pain in pets, and supporting cognitive development in individuals with neurodevelopmental disorders.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically neurostimulation technologies and electrical stimulation systems for biological interventions
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or electrical engineer with expertise in neural interface design, electrical stimulation techniques, and medical device development, possessing advanced knowledge of electrode configurations, signal modulation, and biological response mechanisms
Obviousness Rationale
A PHOSITA would recognize that the neurostimulation technology disclosed in the source patent provides a fundamental platform for broad application across multiple biological domains. The core principles of targeted electrical stimulation, signal modulation, and electrode-based intervention are directly transferable to diverse contexts. The PTD's variations represent predictable extensions of existing neurostimulation techniques by applying known electrical stimulation principles to novel industrial and biological scenarios.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,789 |
|---|---|
| Title | Neurostimulation method and system for active emulation of passive discharge in presence of MRI/EMI interference |
| Assignee(s) | Advanced Neuromodulation Systems, Inc. |